CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that management will discuss the Company’s Toll-Like Receptor - targeted drug discovery and development programs and provide a general corporate overview at the following conferences:
